Stocks
Novo Nordisk A/SNVO
NYSEHealthcarePharmaceuticals$37.96-0.16%
A Denmark-based pharmaceutical manufacturer focused on treatments for diabetes, obesity, and other chronic metabolic diseases. Its portfolio includes insulin products and GLP-1 therapies such as Ozempic and Wegovy, which have driven rapid revenue growth and reshaped the global obesity treatment mark...
Market Cap: $168.7B52W Range: $35.85 – $82.57
Congressional Interest in Novo Nordisk A/S (NVO)
3 members of Congress have disclosed 19 trades in Novo Nordisk A/S (NVO), a Healthcare company. The buy/sell breakdown shows 12 purchases versus 7 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
3
Buys
12
Sells
7
Who in Congress Is Trading NVO?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2010-01-07 | JAMES B. RENACCI | sell | $2,350.21 |
| 2010-01-07 | JAMES B. RENACCI | sell | $2,350.21 |